BridgeMD
Compares treatment options for Acute Kidney Injury (Nontraumatic)
Official title Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patients After Major Surgery
ClinicalTrials.gov ID: NCT05275218
What this study is testing
- What it's testing
- There is no specific therapy for acute kidney injury. It is presumed that supportive measures improve the care and outcome of patients with acute kidney injury.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients (age ≥18 years)
- Moderate or severe AKI ((defined by the 2012 KDIGO criteria, KDIGO stage 2 and 3), determined by either serum creatinine or urine output) within 72h...
- Written informed consent
You likely can't join if
- Dialysis-dependent chronic kidney disease
- Prior kidney transplant
- Infections with human immunodeficiency virus or hepatitis
- Hepatorenal syndrome
- Pregnancy or breast-feeding
- Participation in another treatment trial that investigates a drug that affects the kidney function within the last 3 months
See the full eligibility criteria
- Adult patients (age ≥18 years)
- Moderate or severe AKI ((defined by the 2012 KDIGO criteria, KDIGO stage 2 and 3), determined by either serum creatinine or urine output) within 72h after a surgical procedure
- Written informed consent
- Dialysis-dependent chronic kidney disease
- Prior kidney transplant
- Infections with human immunodeficiency virus or hepatitis
- Hepatorenal syndrome
- Pregnancy or breast-feeding
- Participation in another treatment trial that investigates a drug that affects the kidney function within the last 3 months
- Persons held in an institution by legal or official order
- Persons with any kind of dependency on the investigator or employed by the responsible institution or investigator
The study team makes the final eligibility decision.
Where it's taking place
- Münster, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Münster, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.